Johnson & Johnson vs. Verastem, Inc.
Johnson & Johnson (JNJ) comes out ahead, leading on 8 of 8 compared factors.
Size & Scale
| JNJ | VSTM | |
|---|---|---|
| Market Cap | $651.20 billion | $683.75 million |
| Revenue (TTM) | $97.93 billion | $87.53 million |
| Net Income (TTM) | $21.04 billion | $-202,698,000 |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | VSTM | |
|---|---|---|
| P/E Ratio | 31.51 | — |
| Price / Book | 7.66 | 13.68 |
| Price / Sales | 6.65 | 7.81 |
JNJ leads on 2 of 2 valuation factors.
Profitability
| JNJ | VSTM | |
|---|---|---|
| Net Margin | 21.48% | -231.59% |
| Return on Equity | 24.76% | -405.51% |
JNJ leads on 2 of 2 profitability factors.
Dividend
| JNJ | VSTM | |
|---|---|---|
| Dividend Yield | 1.97% | — |
| Payout Ratio | 62.18 | — |
JNJ and VSTM split the dividend factors evenly.
Risk & Sentiment
| JNJ | VSTM | |
|---|---|---|
| Short Interest | 0.67% | 1.11% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, VSTM overview, VSTM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.